Biopharmas raising money in public or private financings, including: Genprex.

Biopharmas raising money in public or private financings, including: ABVC, Adial, Aslan, Enliven, Imara, Olatec, Sellas.

Xeltis BV has completed a €32 million (US$34 million) series D2 round that will propel the clinical development of its electrospun polymer implants across several indications. The fully synthetic implants promise the best of both worlds, with the mechanical strength required to be fully functional from day one, and bioresorbable properties that cause gradual degradation as endogenous tissue regenerates to form a natural replacement.

Radiopharmaceutical company Fusion Pharmaceuticals Inc. is acquiring a phase II actinium-based alpha-emitter radiopharma program for prostate cancer from Radiomedix Inc.

Med-tech firms raising money in public or private financings, including: Exact Sciences.

Biopharmas raising money in public or private financings, including: Abivax, Apellis, Aprea, Omega, Transcend.

Med-tech firms raising money in public or private financings, including: Bellevue Life Sciences, Current Surgical.